Liver steatosis assessment: correlations among pathology, radiology, clinical data and automated image analysis software.

Quantitating hepatic steatosis is important in many liver diseases and liver transplantation. Since steatosis estimation by pathologists has inherent intra- and inter-observer variability, we compared and contrasted computerized techniques with magnetic resonance imaging measurements, pathologist visual scoring, and clinical parameters. Computerized methods applied to whole slide images included a commercial positive pixel count algorithm and a custom algorithm programmed at our institution. For all liver samples (n=59), including pediatric, adult, frozen section, and permanent specimens, statistically significant correlations were observed between pathology, radiology, and each image analysis modality (r=0.75-0.97, p<0.0001), with the strongest correlations in the pediatric cohort. Statistically significant relationships were observed between each method and with body mass index (r=0.37-0.56, p from <0.0001 to <0.05) and with albumin (r=0.55-0.64, p<0.05) but not with alanine aminotransferase or aspartate aminotransferase. Although pathologist assessments correlated (r=0.64-0.86, 0.92-0.97, and 0.78-0.91 for microvesicular, macrovesicular, and overall steatosis, respectively), the absolute values of hepatic steatosis visual assessment were susceptible to intra- and inter-observer variability, particularly for microvesicular steatosis. Image analysis, pathologist assessments, radiology measurements, and several clinical parameters all showed correlations in this study, providing evidence for the utility of each method in different clinical and research settings.

[1]  E. Brunt,et al.  Nonalcoholic fatty liver disease: pathology and pathogenesis. , 2010, Annual review of pathology.

[2]  O. Cummings,et al.  Misuse of scoring systems , 2011, Hepatology.

[3]  M. Charlton Nonalcoholic fatty liver disease: a review of current understanding and future impact. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  J. Bancroft,et al.  Microtomy: Paraffin and Frozen , 2008 .

[5]  H. Makhlouf,et al.  Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver‐related mortality , 2011, Hepatology.

[6]  K. Batts,et al.  Use of fatty donor liver is associated with diminished early patient and graft survival. , 1996, Transplantation.

[7]  D. Pessayre,et al.  Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. , 1995, Pharmacology & therapeutics.

[8]  Xiaoping Hu,et al.  Quantitative analysis of T2‐correction in single‐voxel magnetic resonance spectroscopy of hepatic lipid fraction , 2009, Journal of magnetic resonance imaging : JMRI.

[9]  Scott L Nyberg,et al.  Assessment of donor liver steatosis: pathologist or automated software? , 2004, Human pathology.

[10]  F. Gordon,et al.  Steatosis in donor and transplant liver biopsies. , 2000, Human pathology.

[11]  J. Jessurun,et al.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.

[12]  H. Alkadhi,et al.  Liver fat quantification by dual-echo MR imaging outperforms traditional histopathological analysis. , 2012, Academic radiology.

[13]  E. van Marck,et al.  Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[14]  N. Young,et al.  Approach to intraoperative consultation for donor liver biopsies. , 2013, Archives of pathology & laboratory medicine.

[15]  D. Brenner,et al.  Correlation between liver histology and novel magnetic resonance imaging in adult patients with non‐alcoholic fatty liver disease – MRI accurately quantifies hepatic steatosis in NAFLD , 2012, Alimentary pharmacology & therapeutics.

[16]  Alia Zubair,et al.  Morphometric Analysis of Hepatic Steatosis in Chronic Hepatitis C Infection , 2009, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

[17]  S. Reeder,et al.  Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy , 2011, Journal of magnetic resonance imaging : JMRI.

[18]  Xiaoping Hu,et al.  Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy--a rapid and accurate technique. , 2009, Radiology.

[19]  W. Jochum,et al.  Use of Severely Steatotic Grafts in Liver Transplantation: A Matched Case-Control Study , 2007, Annals of surgery.

[20]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.

[21]  S. Ukabam,et al.  Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C , 2001, Journal of clinical pathology.

[22]  T. Fishbein,et al.  Use of livers with microvesicular fat safely expands the donor pool. , 1997, Transplantation.

[23]  L. Arnould,et al.  Automated morphometric estimation of liver steatosis. , 1979, Microscopica acta. Supplement.

[24]  C. Cavaro-Menard,et al.  Fuzzy algorithms to extract vacuoles of steatosis on liver histological color images , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[25]  Bruno Turlin,et al.  Assessment of hepatic steatosis: comparison of quantitative and semiquantitative methods in 108 liver biopsies , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[26]  Jun Kong,et al.  Computer-Based Image Analysis of Liver Steatosis with Large-Scale Microscopy Imagery and Correlation with Magnetic Resonance Imaging Lipid Analysis , 2011, 2011 IEEE International Conference on Bioinformatics and Biomedicine.

[27]  D Cascella,et al.  An innovative methodology for the automated morphometric and quantitative estimation of liver steatosis. , 2009, Histology and histopathology.

[28]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[29]  B. Koneru,et al.  Hepatic steatosis and liver transplantation current clinical and experimental perspectives. , 2002, Transplantation.

[30]  Lennart Bodin,et al.  Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting , 2005, Modern Pathology.

[31]  R. Stratta,et al.  FROZEN SECTION EVALUATION OF DONOR LIVERS BEFORE TRANSPLANTATION , 1993, Transplantation.

[32]  R. Kelley,et al.  Familial Reye-like syndrome: a presentation of medium-chain acyl-coenzyme A dehydrogenase deficiency. , 1987, Pediatrics.

[33]  John Hart,et al.  Comparing morphometric, biochemical, and visual measurements of macrovesicular steatosis of liver. , 2011, Human pathology.

[34]  D. Pessayre,et al.  Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. , 1997, Journal of hepatology.

[35]  Pierre-Alain Clavien,et al.  When is steatosis too much for transplantation? , 2006, Journal of hepatology.

[36]  M. Stegall,et al.  Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. , 1993, Transplantation.

[37]  S. Feng,et al.  Steatotic livers for liver transplantation—life-saving but at a cost , 2008, Nature Clinical Practice Gastroenterology &Hepatology.

[38]  Erick M Remer,et al.  The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.

[39]  Zachary Evans,et al.  Development of an unbiased method for the estimation of liver steatosis , 2004, Clinical transplantation.

[40]  B. Neuschwander‐Tetri,et al.  Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease , 2010, Hepatology.

[41]  Elizabeth M. Brunt,et al.  Pathology of nonalcoholic fatty liver disease , 2010, Nature Reviews Gastroenterology &Hepatology.

[42]  Ali H Mokdad,et al.  Increasing prevalence of the metabolic syndrome among u.s. Adults. , 2004, Diabetes care.